UCSF

Tagged: pharmacogenetics

Tamraz is featured PGRN Investigator

Bani Tamraz, PharmD, PhD, is the featured Pharmacogenomics Research Network Investigator (PGRN) for February 2019. An article on the group’s website describes his overall goal to build a patient-oriented program of pharmacogenetics research, teaching, and clinical practice that utilizes genetics for therapy optimization at UCSF and beyond. Read the full article here: Featured PGRN Investigators

20 years chasing the genetic roots of asthma

The UCSF Asthma Collaboratory celebrates 20 years of research on genetic factors in asthma.

Classroom pharmacogenetics, post-hospital medications, and post-brain-surgery drugs take top honors

Studies of pharmacogenetics testing of pharmacy students as a teaching tool, an improved system to resolve medication issues after patients go home from the hospital, and the prophylactic use of an antiseizure drug for brain surgery patients took top honors at the Department of Clinical Pharmacy 18th Annual Spring Research Seminar.

Study discovers why leading gout medication is ineffective for many

Allopurinol, the first-choice medication for treating gout—an excruciatingly painful condition that is the most common form of inflammatory arthritis, afflicts more than eight million Americans, and is on the rise worldwide—is not fully effective in more than half of patients.

Major Mexican genetic study uncovers basis for health differences among Latinos

The most comprehensive genetic study of the Mexican population to date has revealed as much genetic differentiation as the variation between some Europeans and Asians.

Bani Tamraz, PharmD, PhD

Tamraz
Assistant Professor

My primary interest is identification of genetic determinants of drug response through modern methods aimed at addressing pharmacogenomics research and translating that information into new diagnostics and treatment strategies at point-of-care.

Jaekyu Shin, PharmD

Shin
Associate Professor

I teach and precept pharmacy students and work with underserved populations at Zuckerberg San Francisco General Hospital. My research focuses on the clinical application of cardiovascular pharmacogenetic tests and pharmacoepidemiology.

Deanna Kroetz, PhD

Kroetz
Professor

My research seeks to understand the contribution of genetic variation to drug toxicity, to identify genetic biomarkers that can be used to guide effective use of drugs in the treatment of cancer and HIV, and to use genetics to unravel the molecular basis of drug-induced toxicity.

Kathy Giacomini, PhD

Giacomini
Professor & CERSI Co-Director

My research focuses on membrane transporters, which are of great importance to drug disposition and response. I am particularly interested in genetic variants in membrane transporters that are determinants of drug response and in harnessing transporters to enhance drug targeting. 

Drug safety is the aim of UCSF-Optivia research partnership

Pharmacogenetics expert Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences, is leading the UCSF arm of a research partnership in which her team will profile 2,000 prescription drugs against key molecules in the liver and kidney that are responsible for ferrying those dr

Pages